Skip to main content
Biotalys logo

Biotalys — Investor Relations & Filings

Ticker · BTLS ISIN · BE0974386188 LEI · 69940040QC7E3C0G3X07 BR Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2025-10-20 Share Issue/Capital Cha…
Country BE Belgium
Listing BR BTLS

About Biotalys

https://www.biotalys.com/

Biotalys is an agricultural technology (AgTech) company developing a new generation of protein-based biocontrol solutions for crop and food protection. The company utilizes its proprietary technology platform to create a pipeline of effective and safe products with novel modes of action. These solutions are designed to control key crop pests and diseases across the food value chain, contributing to a more sustainable and safer food supply.

Recent filings

Filing Released Lang Actions
Press release Biotalys - regulated information - 20 October 2025.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a press release from Biotalys NV disclosing the total number of voting rights and shares in accordance with the Belgian Act of 2 May 2007. This type of disclosure is a standard regulatory requirement for listed companies to inform the market of their capital structure and voting rights denominator. It does not report a change in a specific major shareholder's position (which would be MRQ), nor is it a report publication announcement (RPA). It falls under the category of general regulatory announcements required by market authorities.
2025-10-20 English
Persbericht Biotalys - gereglementeerde informatie - 20 oktober 2025.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory announcement regarding the total number of voting rights and shares of Biotalys NV, issued in accordance with Article 15 of the Belgian Law on the disclosure of major holdings. It provides the current capital structure, total voting rights, and details on outstanding subscription rights. This type of disclosure is a standard regulatory requirement for listed companies to inform the market of their share capital and voting denominator, which falls under the category of general regulatory announcements (RNS) as it does not fit into specific categories like major shareholding notifications (which are filed by the shareholders) or share issues (which are specific transaction announcements).
2025-10-20 Dutch
Biotalys HY 2025 Report ENG.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half-Year Report 2025' for Biotalys NV. It contains a responsibility statement, business review, and condensed consolidated financial statements (including balance sheet, profit/loss, and cash flows) for the six-month period ending June 30, 2025. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-09-18 English
Biotalys HY 2025 Report NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'HALFJAAR RAPPORT 2025' (Half-Year Report 2025) for Biotalys NV. It contains a comprehensive set of financial statements, including a balance sheet, income statement, cash flow statement, and notes to the financial statements, as well as a management overview and an independent auditor's report. This aligns perfectly with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-18 Dutch
Biotalys Reports HY 25 Financial Results and Business Highlights_18 September 2025.pdf
Earnings Release Classification · 100% confidence The document is a press release titled 'Biotalys Reports Half-Year 2025 Financial Results and Business Highlights'. It provides a summary of financial performance, business milestones, R&D updates, and corporate highlights for the first half of the year. While it mentions that the full interim report is available via a link, the document itself serves as the initial announcement of these results, including key financial tables and management commentary. According to the filing definitions, this fits the 'Earnings Release' (ER) category, as it is the primary announcement of periodic financial results. H1 2025
2025-09-18 English
Biotalys rapporteert financiële resultaten en hoogtepunten voor H1 2025_18 september 2025_.pdf
Earnings Release Classification · 100% confidence The document is a press release titled 'Biotalys reports financial results and business highlights for the first half of 2025'. It provides a summary of financial performance, R&D updates, and corporate highlights for the six-month period ending June 30, 2025. While it contains financial tables and mentions the availability of the full interim report on the company website, the document itself serves as the initial announcement of these results (Earnings Release). It follows the standard structure of an earnings release, including management commentary, key highlights, and details for an upcoming earnings call. H1 2025
2025-09-18 Dutch

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.